To understand the molecular events which are important in leucocyte trafficking in cutaneous inflammation, poison ivy/oak extract was applied topically to the skin, and the simultaneous assessment of a variety of clinical and immunopathological parameters peribrmed. The clinical response of subjects was divided into three main groups: I. 2-24 h after application, before the onset of erythema: H. 48 h-1 week after application during maximal clinical changes; ill. 2-3 weeks after application when the inflammation had subsided. Six different biopsies per subject were evaluated over the study period and the density of dermal cellular infiltrate, and the distribution of intercellular adhesion molecule-1, (ICAM-1), endothelial leucocyte adhesioti molecule-1. (EI^M-1), vascular cell adhesion molecule-1. (VCAM-1), interleukin 8 (IL-8) and tumour necrosis factor-alpha (TNF-a). determined. Eight hours after exposure, before lymphocytes and monocytes had entered the dermal interstitium or epidermis, the keratinocytes expressed TNF-a and TCAM-l, whilst the endothelial cells expressed EIAM-1. VCAM-1 and lCAM-1. Group II biopsies revealed increasing keratinocyte expression of TNF-a and ICAM-1 with the appearance of IL-8. which correlated with the onset of epidermal T-cell trafficking. The endothelium was strongly positive for ELAM-1 and VCAM-1, hut there was no infiux of neutrophils. Group III biopsies showed a decrease in the expression of ICAM-1. VCAM-1 and FLAM-1 by both keratinocytes and endothelium with a reduction in epidermal/dermal inflammation, although the endothelial cell staining of VCAM-1 and ELAM-1 did not completely disappear. These results suggest that on exposure to poison ivy/oak, keratinocytes rapidly produce TNF-a which leads to an early autoinduction of ICAM-1, and later IL-8. There is also a paracrinemediated induction and augmentation of underlying endotheliai cell ELAM-1. VCAM-1 and ICAM-1.
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The cellular events induced in human skin following epicutaneously applied allergens include early morphological changes in endothelial cells, within 4-8 h. which precede the migration of lymphocytes into the dermis.' However, after 24-48 h. lymphocytes are observed bound to endothelial cells of the superficial vascular plexus, and entering the dermis and epidermis.' These cellular alterations imply that resident cells, keratinocytes, endothelial cells and perivascular dermal dendrocytes. can become rapidly activated and produce molecular mediators for the recruitment of circulating mononuclear cells into the derm is/epidermis. We previously observed that urushiol (the active ingredient in Correspondence: Dr B.I.Nlckoloff.
poison ivy/oak) directly induces keratinocyte ICAM-1. prior to dermal T-cell infiltration, with dermal dendrocytes appearing as prominent early constituents of the inflammatory reaction.-To define the molecular events responsible for the migration of infiammatory cells, we have applied a poison ivy/oak extract to normal skin and taken sequential biopsies.^ A variety of leucocyte adhesion molecules (ICAM-1. EI.AM-1. VCAM-1). a T-cell chemotactic factor (IL-8). and a cytokine (TNF-a). known to regulate adhesion molecule and 11,^8 production in co-ordination.' were assessed immunohistochemically. At the same time the sequence of trafficking of infiammatory cells in the skin during the evolution of infiammation was determined.^'*
Methods

Patients
Seven adult volunteers (four males, three females; age range 26-54 years) with a positive history for poison ivy dermatitis, who were otherwise in good health without any current skin disorder, and not taking any medication, were selected for study. All 4-mm punch biopsies were obtained alter informed consent with the approval of the University of Michigan Human Subjects Committee. Portions of a tonsil were also obtained from a patient undergoing elective tonsillectomy.
Induction of inflammation and biopsy procedure
A poison ivy/oak mixture 1: 50 {w;v) in alcohol (Hollister-Stier. Elkhart. IN. U.S.A.) was applied using the Altest System (Sodertalje. Sweden) to six diflerent sites (5 mm diameter, 5 cm apart) on the flexor foreann of each volunteer. The patch-test reaction sites were divided into three diflerent groups.^ Group I biopsies were obtained 2-24 h after application of the poison ivy/oak mixture, before the onset of erythema or any other detectable clinical change. Group II biopsies were obtained 48 h-1 week after application when there were maximal clinical changes, and Group III biopsies were obtained 2-3 weeks after application when the inflammation had subsided, and there was oniy mild, residual erythema. Each volunteer had a baseline (pre-application) biopsy and then sequential biopsies of Group 1. Group II and Group III sites were taken, with no more than six biopsies taken from each subject. A representative biopsy protocol would be as follows: baseline: 4, 8. and 24 h (Group I); 48 h or 1 week (Group II); 2 or 3 weeks (Group III).
Evaluation procedures
Clinical features. The patch-test sites were graded as follows: 0. no reaction; 1. erythema; 2, erythema and oedema; 3. erythema, oedema, and vesiculation.
Hislopathology. The slides were assessed by two of the authors (CEMG, B]N). The dermal cellular infiltrate was composed primarily of lymphocytes and monocytes/ macrophages (without neutrophiis) and was graded semiquantitatively from 0-4 as follows: 0-1. no increase above the normal, pretreatment biopsy, or a few perivascular mononuclear cells; 2, a mild increase in perivascular mononuclear cells with rare scattered interstitial cells; 3. a moderate increase in perivascular cells accompanied by an easily recognizable dermal interstitial and epidermal influx of mononuclear cells and 4. an intense perivascular and interstitial mononuclear cell inflltrate with numerous intraepidermal cells.
Immunohistochemistrif. The punch biopsies were orientated and mounted on gum tragacanth (Sigma Chemical Co.. St Louis. MO. U.S,A.). snap frozen in isopentane chilled in liquid nitrogen, and then stored at -70°C until use, Cryostat sections (5 /im) were fixed in cold (4°C) acetone and incubated with primary monoclonal antibodies (MAbs) or antisera diluted In phosphatebuffered saline (PBS) containing 1% bovine serum albumin (Sigma Chemical Co.) for 4S min at room temperature. The sections were then washed in PBS. and an avidin-biotin immunoperoxidase technique was used (Vectastain. Vector I.abs. Burlingame. CA. U.S.A.) as previously described.^ with 3-amino 9-ethylcarbazoIe as the chromogen and counterstained with 1% haematoxylin.
The MAbs used were BB11 (anti-EI^AM-1) and RR1 /1 (anti-ICAM-l) obtained from Drs R. Lobb and C. Benjamin (Biogen Inc.. Boston. MA. U.S.A.) and DrT. Springer (Dana Tarber Cancer Institute, Boston. MA. U.S.A.), respectively: MAb 4B9 {anti-VCAM-1) was produced as previously described."' Staining of human umbilical vein endothelial cells (obtained courtesy of Dr R. Marks. University of Michigan) before and after exposure to TNF-a (2 50 U/ml: Biogen Inc.) for 6 and 24 h using these anti-EI^M-1 and anti-VCAM-1 antibodies produced identical results to those previously published (data not shown).''' The highly purifled rabbit antisera against human TNF-a and IL-8 was provided by Dr S.Kunkel. The sensitivity and the specificity of the rabbit anti-TNF-a and IL-8 sera was confirmed by comparison to pre-immune rabbit sera, as well as neutralization preincubation studies with recombinant TNF-a and lL-8 as previously described.*^ Other MAbs used included Leu 6 (anti-CDl. Becton Dickinson. Burlingame. CA. U.S.A.). Tl 1 (anti-CD2, a pan-T cell marker. Coulter Immunology. Hialeah. FL. U.S.A.). and EBM 11 (anti-monocyte/ macrophage; Dako Corp. Santa Barbara. CA. U.S.A.). The specific dilution and antibody concentrations used were: BBll (1:50: 20 /tg/ml); 4B9 (1:50; 20 /ig/ml): RRl/1 (1:10.000: 1 ;jg/ml); TNF-a and IL-8 (1:2000): Leu 6 (1:20: 2-5 /xg/ml) and T 11 (1:50: 10 /jg/ml); EBM 11 (1:100: 4/^g/ml).
Keratinocyte ICAM-1 expression was graded as: 0, no epidermal staining: 1, less than 2 5% of all epidermal keratinocytes/section were positive: 2. 25-50%; 3, 50-75%: 4. >75%. The same scoring system was used to measure the degree of epidermal keratinocyte TNF-a and iIL-8 positivity.
Endnthelial cell adhesion molecule (ELAM-1, ICAM-1 and VCAM-1) expression was assessed by the following scoring system: 0. negative or no vessel reactivity; 2. weak reactivity that was generally detectable on less than five vessels per section; 4, moderate reactivity easily detectable on 6-10 vessels per section: 6, strong reactivity with easily detectable and diffuse staining of more than 10 vessels per section. It should be noted that the positively scored vessels were primarily those of the superficial vascular plexus and not larger vessels (arteriolar) or lymphatic endothelium.
Results
Normal skin and tonsil
The baseline biopsies of normal skin revealed no reactivity for ELAM-1 and VCAM-l on endothelial cells and only weak ICAM-1 staining of endothelial cells as sweat duct epithelium were positive for TNF-a. IL-8 positive cells were confined to eccrine duct epithelium and acrosyringium." This lL-8 and TNF-a reactivity in normal skin, as well as the staining pattern described below was judged to be specific as it was not observed using pre-immune rabbit serum, and pre-ahsorption of the anti-serum with recombinant 11.-8 and TNF-a resulted in an absence of staining.** A summary of the clinical, pathological and immunohistochemical results for pretreatment and post-treatment biopsies is shown in Figure 1 .
Croup I: pre-erythematous skin reactions to poison ivy/oak
During the first 24 h following application of poison ivy/ oak, the skin was essentially clinically unchanged, with only a slight degree of erythema detected in one patient ( Fig. 1) The cellular infiltrate during this period was only slightly increased over baseline levels, with a marginal increase in the perivascular lymphocyte population ( (Fig. 4) during this period and this could be detected as early as 4 h after application of the poison ivy/oak extract. Because there was a near-simultaneous induction of the expression of ICAM-1 by keratinocytes and of EIAM-I and VCAM-l by endothelial cells, suggesting the local production of an activating cytokine." we sought to identify TNF-a in these sections. TNF-a is the only known cytokine which can induce all three adhesion molecules on these different cell types in Wfra.'^ ''' The epidermal keratinocytes showed an increased expression of TNE-a during this time period with little or no staining of any other cell type (Fig. 5) . There was only a slight increase in keratinocyte IL-8 expression, which became more noticeable 48 h after treatment (Eig. 6).
and more prominent ICAM-1 expression of dermal dendritic cells in the upper dermis, particularly in the area between the tips of the dermal vascular plexus and the base of the keratinocytes (Eig. 2). It appeared that these dermal dendritic cells were more strongly ICAM-1 positive than dermal dendritic cells in the normal and untreated skin.'^ The prominent expression of ICAM-1 by basal keratinocytes, dermal dendrocytes. and the endothelial cells seemed to produce an almost continuous network of cellular adhesion molecules in the upper portion of the treated skin, which probably comprised a dermal microvascular reactive unit.^" The endothelial
. Jw # Figure 6 . IL-S expression by epidermal keratinocytes 48 h after treatment, accompanied by the movement of lymphocytes into the epidermis.
Group U: inflammatory phase of poison ivy/oak reaction
Two days to 1 week following application of poison ivy/ oak. the skin became erythematous with oedema and vesiculation. There was variation between patients in the degree and time of onset for each of these parameters,-but all patients eventually reached a clinical score of at least 20. The cellular infiltrate was greatly increased with prominent perivascular and interstitial dermal collections of lymphocytes, monocytes and macrophages, but no neutrophils. Mononuclear cells also began entering the epidermal compartment, with concomitant spongiosis and microvesiculation in four cases. The dermal and epidermal lymphocytes were negative for ELAM-1 and VCAM-I. Epidermal keratinocyte ICAM-1 expression gradually increased, as did endothelial staining for ICAM-1. ELAM-1 and VCAM-1. There was a sUght decrease in keratinocyte TNE-a staining, but increased keratinocyte n.-8 staining as noted above (Eig. 6).
Group III: post-inflammatory phase
After 2-3 weeks, clinical examination of the skin revealed only a slight degree of residual erythema and scaling with no oedema or other changes. The cellular infiltrate had also substantially decreased compared to the Group II samples, and was approaching the baseline/ group I values. Epidermal keratinocyte ICAM-1 was only focally present in three of our patients, and undetectabie in the other four. However, the endothelial cell expression of ICAM-1, ELAM-1 and VCAM-1. while diminished, was still elevated over baseline values indicating persistent expression of both ELAM-1 (Fig. 7a) and VCAM-1 (Fig. 7b) . The epidermal keratinocyte TNF-a and IL-8 staining pattern had largely reverted back to baseline levels.
Discussion
This experimental model was designed to detect in Wvo the molecular mediators of adhesive interactions between leucocytes and cultured cytokine-activated endothelial cells with neutrophiis, lymphocytes and determined where and when these molecules were expressed by indigenous and migrating cells that participate in adhesive interactions during the course of cutaneous inflammation. From tissue culture experiments it is known that at least three distinct mechanisms are involved for lymphocyte adhesion to endothelial cells.'"' The studies on the combination of human endothelial cells, with neutrophiis. lymphocytes and monocytes have been reviewed."" In this present study we have assessed three distinct adhesion molecules, a T-ce!I chemotaxin (IT^-8) and a modulatory cytokine (TNF-2). together with the associated accumulation of leucocytes in an in-Wvo human system."*'' Endothelial cell Ei,AM-l was induced within 4-8 h following topical application of the poison ivy/oak mixture, and this induction preceded migration of lymphocytes into the dermis. EI,AM-1 expression was not associated with an influx of neutrophiis as predicted by in vitro experiments.'** or as observed in baboon skin following intradermal injections of TNF-a and IFN-y.'** Moreover, in vivo BLAM-1 expression was more persistent (> 3 weeks) than previously observed for cultured endothelial cells'* and endothelium in short-term skin organ cultures incubated with various cytokines.'" in which ELAM-1 expression was essentially absent after only 24 h. The differences in results between cultured endothelial cells'* and the current study may be partly explained by the experimental methods used. The study of cultured endothelial cells emphasized cell-surface immunoreactivity. whereas in frozen sections of intact skin specimens fixed with acetone, the resulting membrane permeabilization does not allow easy distinction between cytoplasmic and ceil surface staining. It should be noted that different ELAM-1 antibodies have been used, and it is possible that the H4/18 antibody recognizes a different epitope on endothelial cells than the currently used BBll antibody. However, it is also possible that the regulation of EIAM-1 expression and functional binding interactions between neutrophiis and cultured endothelial cells is quite different from regulatory pathways in vivo. There may be pulses of endotheiial cell activation in vivo, operating on a large reservoir of vascular-lining cells, which could give the appearance of persistence by individual cells, of ELAM-1 expression and a cell-to-cell contiguity.
Endothelial cell VCAM-1 was induced within 4-8 h following topical application of the poison ivy/oak mixture, and this induction preceded migration of lymphocytes into the dermis. This VCAM-1 expression occurred much earlier than that observed at 72 h in a delayed-type. cutaneous inflammatory reaction.' However, the rapid induction and prolonged expression of endothelial VCAM-1 is very similar to the results obtained by treating cultured endothelial cells with TNF-a.'^ The perivascular dermal dendritic cells were also VCAM-1 positive both in untreated control skin, and in inflamed skin which agrees with a previous study using a different anti-VCAM-1 antibody (INCAM-l 10) . ' The induction of keratinocyte ICAM-1 occurred very rapidly before the development of a dermal T-Iymphocytic infiltrate and an ICAM-1 network was formed in the upper portion of the skin involving endothelial cells, dermal dendritic cells, and basal keratinocytes.^ At 2-3 weeks post-treatment when the cutaneous inflammation was resolving and there was no further trafficking of mononuclear cells into the epidermis, the kcratinocytcs became ICAM-1 negative. This temporal and spatial colocalization of keratinocyte ICAM-1 with intraepidermal lymphocyte trafficking'' is found in several skin diseases (psoriasis, lichen planus. alopecia areata) before and during treatment with cyclosporin A.^'"^' We previously observed the ability of urushiol to activate directly keratinocyte ICAM-1 expression,' and noted that urushiol strongly induced TNF-a expression on cultured keratinocytes.'' We therefore examined whether TNF-a protein expression could be detected early in our in vivo model, as this is the only known cytokine capable of inducing endothelial cell ELAM-1. VCAM-1 and keratinocyte ICAM-1 expression.
Keratinocyte TNF-a expression was induced within 4-8 h following topical application of the poison ivy/oak mixture, and the keratinocyte was the principal cutaneous cell type which was TNF-a positive. The ability of the keratinocytes to rapidly respond to urushiol by producing TNF-a. which could autoinduce keratinocyte ICAM-1 and then activate the underlying dermal endothelial cells, supports our earlier contention that the keratinocyte regulates the movement of dermal cells.*'' ''^'^ While the notion that the 'activated' endothelial cell is pivotal in T-cell-mediated inflammatory reactions has gained support in recent years,'-^'-'' the current results suggest that the epithelium, and perhaps perivascular dendritic macrophages. are very important in the endothelial cell-T-cell interactions, and may even initiate them."* Keratinocyte n.-8 expression occurred somewhat later than the appearance of TNF-a, but correlated well with the migration of T lymphocytes towards the epidermis. This in vivo correlation involving keratinocyte TNF-a expression with the co-ordinated induction of ICAM-1 and IL-H. resembles that found in vitro and supports the notion that keratinocyte-derived 11.-8 is an Important T-cell chemotaxin both in vitro, and in vivo.^Î n conclusion, these results indicate that the molecular basis for the precise cellular movement of leucocytes during the genesis, evolution, and termination of cutaneous inflammation induced by poison ivy/oak involves the production of TNF-a by epidermal keratinocytes. with the subsequent induction and diminution of multiple adhesion molecules on endothelial cells (ELAM-1, VCAM-l) and keratinocytes {ICAM-1). as well as the production of chemotactic factors such as IL-8. While there are almost certainly other components of this molecular and cellular network beyond those studied here, this experimental system can further our understanding of normal immunohomeostasis and the pathophysiology of acute and chronic cutaneous inflammation.
